RT @carlatreloar: @GregDore2 @Oevrehusdk @StineNielsenEPI @arjmcauley @jasongrebely @martinkaberg @INHepSU And here’s two we prepared earli…
@GregDore2 @Oevrehusdk @StineNielsenEPI @arjmcauley @jasongrebely @martinkaberg @INHepSU And here’s two we prepared earlier! Our work on what people who inject want from Hep c treatment, beyond cure. And, acceptability of a new patient reported outcome mea
Papers associated with the PROMs study below. Contact @carlatreloar for more info. What other outcomes beyond cure https://t.co/qskQPTYMMn What other barriers to hep c treatment https://t.co/4FvIA5Xble Acceptability of PROM https://t.co/I7FG6VT5i4
@DrGrahamBrown @Annie_Madden_ @CSRH_UNSW Here’s our papers from this work. 2 are open access - please contact for other. What other outcomes beyond cure https://t.co/lq4GO75obU What other barriers to hep c treatment? https://t.co/TVMwFidNbf Acceptabili
RT @carlatreloar: Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co…
RT @carlatreloar: Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co…
RT @carlatreloar: Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co…
RT @carlatreloar: Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co…
RT @carlatreloar: Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co…
Its out! Our last paper on patient reported outcomes for people who inject drugs undertaking DAA treatment. https://t.co/oOBkpPsep4 1/5
Interesting and as we know the holistic approach is important. The balance is so crucial in meeting and supporting with immediate health, psychological and life needs without becoming confluence with a very powerful process.
Happy to participate in similar research! Development and pre-testing of the Patient Engagement In Research Scale (PEIRS) to assess the quality of engagement from a patient perspective https://t.co/oHlQV8yoJ3 @t_hainstock @chaD4quality @SofiaRB_88 @mlgagno
Yes @carlatreloar @Jo_S_Neale and @Annie_Madden_ these #PROM for #PWID living w #hepC are def worth exploring further @SGoutzamanis @MargaretHellard
@HenryEChang @SGoutzamanis @Josephsdoyle @higgspg @MargaretHellard @Monash_SPHPM @latrobe @BurnetInstitute @hepfreenyc @EndHepCSF @EndHepCNY @HCVNEWDRUGS @hcvresearchnews @EASLnews @AASLDtweets @HepFreeHawaii @hepcure See our work on what should be measure
You can read this article for free here: https://t.co/x7uyaqNwax
RT @PatientJournal: New publication in The Patient investigates acceptability of PRMs for hep C treatment in people who inject drugs. @carl…
RT @PatientJournal: New publication in The Patient investigates acceptability of PRMs for hep C treatment in people who inject drugs. @carl…
RT @PatientJournal: New publication in The Patient investigates acceptability of PRMs for hep C treatment in people who inject drugs. @carl…
New publication in The Patient investigates acceptability of PRMs for hep C treatment in people who inject drugs. @carlatreloar @Annie_Madden_ https://t.co/LdyUO1zhSm